*** Need an answer to your GCP query ? Post your query at HelpDesk ***
Follow us on
Process validation

Establishing by objective evidence that a process consistently produces a result or product meeting its predetermined specifications.
 Forums
Board Index Latest Posts Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
 Subject :CONSORT III (2010).. 2010-03-29 12:53:28 
GCP HelpDesk
Moderator
Joined: 2009-06-18 15:31:58
Posts: 62
Location: 
Dear Friends,
 
The CONSORT (Consolidated Standards of Reporting Trials) guidelines third revision was released recently. CONSORT guidelines were established in 1996 and the second revision was made in 2001.
 
Please find attached articles published in BMJ (And also in many other journals). The first one gives the significant changes made in CONSORT 2010 and the other is an elaborated explanation of every item in CONSORT 2010.
 
Kind regards,


Attachments
 Changes in CONSORT 2010.pdf [313 KB] ::
 CONSORT III.pdf [636 KB] ::
IP Logged
GCP HelpDesk
Page # 


Powered by ccBoard